Brief: 4D Molecular Therapeutics Q3 Net Income USD -78.056 Million Vs. IBES Estimate USD -74.2 Million
BRIEF-4D Molecular Therapeutics Q3 Net Income USD -78.056 Million Vs. IBES Estimate USD -74.2 Million Nov 12 (Reuters) - 4D Molecular Therapeutics Q3 basic EPS USD -1.08.
- Q3 operating expenses USD 85.363 million
- Q3 revenue USD 4.145 million vs. IBES estimate USD 2.7 million
- Q3 operating income USD -81.218 million vs. IBES estimate USD -79 million
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
4D Molecular Therapeutics Q3 net loss widens on higher costs
Brief: 4D Molecular Therapeutics Q3 Net Income USD -78.056 Million Vs. IBES Estimate USD -74.2 Million
4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens